Selected research
Market Outlook & Growth Opportunities
Global Iclusig Market Outlook and Growth Opportunities 2026
Market perspective
The global Iclusig market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Iclusig is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Iclusig is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Iclusig is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Iclusig market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Iclusig market include ARIAD Pharmaceuticals. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Iclusig market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Iclusig and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Iclusig sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Iclusig market size, projected growth trends, production technologies, key applications, and end-use industries.
Iclusig Segment by Company
ARIAD Pharmaceuticals
Iclusig Segment by Type
45mg
15mg
Iclusig Segment by Application
CML
ALL
Iclusig Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Iclusig status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Iclusig market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Iclusig significant trends, drivers, influence factors in global and regions.
6. To analyze Iclusig competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iclusig market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Iclusig and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iclusig.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Iclusig market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Iclusig industry.
Chapter 3: Detailed analysis of Iclusig manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Iclusig in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Iclusig in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 45mg
- 15mg
Applications
- CML
- ALL
Companies covered
- ARIAD Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Iclusig Sales Value (2021-2032)
- 1.2.2 Global Iclusig Sales Volume (2021-2032)
- 1.2.3 Global Iclusig Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Iclusig Market Dynamics
- 2.1 Iclusig Industry Trends
- 2.2 Iclusig Industry Drivers
- 2.3 Iclusig Industry Opportunities and Challenges
- 2.4 Iclusig Industry Restraints
3 Iclusig Market by Company
- 3.1 Global Iclusig Company Revenue Ranking in 2025
- 3.2 Global Iclusig Revenue by Company (2021-2026)
- 3.3 Global Iclusig Sales Volume by Company (2021-2026)
- 3.4 Global Iclusig Average Price by Company (2021-2026)
- 3.5 Global Iclusig Company Ranking (2024-2026)
- 3.6 Global Iclusig Company Manufacturing Base and Headquarters
- 3.7 Global Iclusig Company Product Type and Application
- 3.8 Global Iclusig Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Iclusig Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Iclusig Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Iclusig Market by Type
- 4.1 Iclusig Type Introduction
- 4.1.1 45mg
- 4.1.2 15mg
- 4.2 Global Iclusig Sales Volume by Type
- 4.2.1 Global Iclusig Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Iclusig Sales Volume by Type (2021-2032)
- 4.2.3 Global Iclusig Sales Volume Share by Type (2021-2032)
- 4.3 Global Iclusig Sales Value by Type
- 4.3.1 Global Iclusig Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Iclusig Sales Value by Type (2021-2032)
- 4.3.3 Global Iclusig Sales Value Share by Type (2021-2032)
5 Iclusig Market by Application
- 5.1 Iclusig Application Introduction
- 5.1.1 CML
- 5.1.2 ALL
- 5.2 Global Iclusig Sales Volume by Application
- 5.2.1 Global Iclusig Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Iclusig Sales Volume by Application (2021-2032)
- 5.2.3 Global Iclusig Sales Volume Share by Application (2021-2032)
- 5.3 Global Iclusig Sales Value by Application
- 5.3.1 Global Iclusig Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Iclusig Sales Value by Application (2021-2032)
- 5.3.3 Global Iclusig Sales Value Share by Application (2021-2032)
6 Iclusig Regional Sales and Value Analysis
- 6.1 Global Iclusig Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Iclusig Sales by Region (2021-2032)
- 6.2.1 Global Iclusig Sales by Region: 2021-2026
- 6.2.2 Global Iclusig Sales by Region (2027-2032)
- 6.3 Global Iclusig Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Iclusig Sales Value by Region (2021-2032)
- 6.4.1 Global Iclusig Sales Value by Region: 2021-2026
- 6.4.2 Global Iclusig Sales Value by Region (2027-2032)
- 6.5 Global Iclusig Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Iclusig Sales Value (2021-2032)
- 6.6.2 North America Iclusig Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Iclusig Sales Value (2021-2032)
- 6.7.2 Europe Iclusig Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Iclusig Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Iclusig Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Iclusig Sales Value (2021-2032)
- 6.9.2 South America Iclusig Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Iclusig Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Iclusig Sales Value Share by Country, 2025 VS 2032
7 Iclusig Country-level Sales and Value Analysis
- 7.1 Global Iclusig Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Iclusig Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Iclusig Sales by Country (2021-2032)
- 7.3.1 Global Iclusig Sales by Country (2021-2026)
- 7.3.2 Global Iclusig Sales by Country (2027-2032)
- 7.4 Global Iclusig Sales Value by Country (2021-2032)
- 7.4.1 Global Iclusig Sales Value by Country (2021-2026)
- 7.4.2 Global Iclusig Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Iclusig Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Iclusig Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Iclusig Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Iclusig Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Iclusig Sales Value Growth Rate (2021-2032)
- 7.9.2 France Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Iclusig Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Iclusig Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Iclusig Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Iclusig Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Iclusig Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Iclusig Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Iclusig Sales Value Growth Rate (2021-2032)
- 7.16.2 China Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Iclusig Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Iclusig Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Iclusig Sales Value Growth Rate (2021-2032)
- 7.19.2 India Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Iclusig Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Iclusig Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Iclusig Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Iclusig Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Iclusig Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Iclusig Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Iclusig Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Iclusig Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Iclusig Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Iclusig Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Iclusig Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Iclusig Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Iclusig Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Iclusig Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Iclusig Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Iclusig Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 ARIAD Pharmaceuticals
- 8.1.1 ARIAD Pharmaceuticals Company Information
- 8.1.2 ARIAD Pharmaceuticals Business Overview
- 8.1.3 ARIAD Pharmaceuticals Iclusig Sales, Value and Gross Margin (2021-2026)
- 8.1.4 ARIAD Pharmaceuticals Iclusig Product Portfolio
- 8.1.5 ARIAD Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Iclusig Value Chain Analysis
- 9.1.1 Iclusig Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Iclusig Sales Mode & Process
- 9.2 Iclusig Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Iclusig Distributors
- 9.2.3 Iclusig Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst